Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer
Status:
Completed
Trial end date:
2017-02-10
Target enrollment:
Participant gender:
Summary
Test the safety, immune response and efficacy of GVAX pancreas vaccine (with
cyclophosphamide) and CRS-207 compared to GVAX pancreas vaccine (with cyclophosphamide) alone
in adults who have failed or refused prior treatment for metastatic pancreatic cancer.